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   Ferrimagnetic Fe3O4 nanoparticles as a hyperthermia agent for liver cancer 
have been limited by the large size and low specific loss power (SLP). 
Accordingly, a new ferrimagnetic nanoparticle agent with a smaller size, a 
narrower size distribution and a higher SLP, is required for intra-arterial 
hyperthermia modality.  
   In this thesis, ferrimagnetic MFe2O4 (Ni, Co, Mg) nanoparticles were 
synthesized by conventional sol-gel method to investigate and compare the 
feasibility for a hyperthermia agent. AC magnetically induced heating 
temperature (TAC,mag) of the synthesized nanoparticles in the size range of 
30~40 nm in diameter was measured in solid state at the biologically and 
physiologically tolerable range of magnetic field (Happ =140 Oe) and 
frequency (fapp=110 kHz). In addition, MTT assay (methylthiazol tetrazolium 
bromide test) using normal rat liver epidermal cells, was also investigated for 
evaluating cytotoxicity.  
   In the second part, ferrimagnetic MgFe2O4 nanoparticles that exhibited the 
fastest frequency response, the highest AC heat power generation and high 
biocompatibility, were chemically and mechanically modified by a modified 
sol-gel synthesis process in order to achieve higher SLP for intra-arterial 
hyperthermia agent applications while maintaining a small size and a narrow 
size distribution. Ferrimagnetic MgFe2O4 nanoparticles were synthesized by 
controlling calcining temperatures (400 °C, 500 °C and 600 °C) with the fixed 
sintering temperature (700 °C). Then, Ferrimagnetic MgFe2O4 nanoparticles 




fixed calcining temperature (600 °C) that exhibited the highest SLP. Finally, 
ball milling process with different ball sizes (diameter : 5 mm, 3mm) was 
added between the fixed calcining temperature (600 °C) and sintering 
temperature (850 °C) in order to mechanically modify the nanoparticles. The 
crystal structure, mean particle size, size distribution and magnetic properties 
of the modified ferrimagnetic MgFe2O4 nanoparticles were measured to 
investigate the effect of each process on the synthesized nanoparticles. In 
addition, TAC,mag in solid state and a ferrofluid as well as emulsion state where 
the oleic acid coated nanoparticles were mixed with lipiodol, was also 
measured to evaluate the feasibility for the clinical use of liver cancer 
treatment. The ferrimagnetic MgFe2O4 nanoparticles modified by calcining 
temperature of 600 °C, ball milling process (ball diameter: 3 mm) and 
sintering temperature of 850 °C, had proper size (~40 nm), narrower size 
distribution (~20 %) and higher SLP (525 W/g) in a ferrofluid. In addition, the 
oleic acid coated ferrimagnetic MgFe2O4 nanoparticles could be well mixed 
with lipiodol and it exhibited high AC heating characteristics, enabling them to 
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CHAPTER 1. INTRODUCTION 
 
CHAPTER 1  
INTRODUCTION 
 
1.1 Background and Motivation 
   In recent years, although superparamagnetic nanoparticles through 
intravenous injection have been primarily considered as a local hyperthermia 
agent due to their bio-feasible small particle size and easy control of surface 
modification for water dispersible (mono-dispersible) nanofluids, 
ferrimagnetic nanoparticles and the water dispersible ferrofluids have also 
been used and considered as a hyperthermia agent due to their sufficiently 
high AC magnetically-induced heating characteristics and other potential bio-
applications such as a MRI contrast agent, a multi-functional drug delivery 
agent and a cell targeting agent etc. Accordingly, ferrimagnetic Fe3O4 
nanoparticles with a mean diameter of 100~200 nm have been clinically used 
as a local hyperthermia agent for liver cancers through intra-arterial injection 
[1,2]. However, the ferrimagnetic Fe3O4 nanoparticles were found to be 
biotechnically limited by both "side effects" caused by severe aggregation of 
the nanoparticles during intra-arterial injection due to a large particle size and 
caused by the systematic problem required a large amount of nanoparticles 
due to a lower specific loss power (SLP) at the biologically and 
physiologically tolerable range of AC magnetic field [2-5]. Therefore, the 
development of a newly designed ferrimagnetic nanoparticle agent, which has 
a smaller particle size, a narrower size distribution as well as exhibits a higher 
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   MFe2O4 (Ni, Mg, Co) ferrite magnetic materials have been paid attention 
to be a hyperthermia agent because of their wide range of size, diversity, and 
chemical stability as compared to metal nanoparticles [3]. CoFe2O4 is a hard 
magnetic material with large coecivity and high anisotropy energy leading to 
large hysteresis loss [6]. NiFe2O4 and MgFe2O4 are soft magnetic materials 
leading to relatively fast frequency response [7, 8]. Particularly, MgFe2O4 
nanoparticles have been paid considerable attention to be a potential 
hyperthermia agent [3, 4]. The main reason is that magnesium not only makes 
magnetic property softer leading to a larger DC hysteresis area that is a crucial 
factor but it is also a vital element which plays a major role in many metabolic 
processes in the human body as well as in neuron bioelectric activity [6-7].  
 
1.2. Research Objectives  
   The main objective of this thesis is the development and modification of 
ferrimagnetic MgFe2O4 nanoparticles in order to achieve the clinical use of 
liver cancer treatment in intra-arterial hyperthermia modality. The specific 
objectives of this work were to: 
1) investigate and compare AC heating generation ability of ferrimagnetic 
MFe2O4 (Ni, Mg, Co) nanoparticles in the size range of 30~40 nm 
synthesized by conventional sol-gel method 
2) explore in-vitro cytotoxicity study of the ferrimagnetic MFe2O4 (Ni, 
Mg, Co) nanoparticles using normal rat liver epidermal cells   
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temperatures, sintering temperatures and ball milling process, 
respectively 
4) investigate and compare AC heating generation ability of the modified 
ferrimagnetic MgFe2O4 nanoparticles in solid state, a ferrofluid and 
emulsion state that mixed with lipiodol 
   
1.3. Organization of Thesis 
   Chapter 1 presents the background, motivations, and objectives of this 
thesis. Chapter 2 reviews the current literature and describes in detail the 
background information of the project. Chapter 3 presents synthesis methods 
(conventional and modified sol-gel methods). In addition, the various 
characterization techniques are introduced. In chapter 4, ferrimagnetic MFe2O4 
(Ni, Mg, Co) nanoparticles are investigated and compared by AC heating 
generation ability and biocompatibility. Furthermore, ferrimagnetic MgFe2O4 
nanoparticles synthesized by the modified sol-gel method are also investigated 
and compared. The physical and magnetic properties as well as AC heating 
characteristics were also measured. Finally, chapter 5 concludes with a 









   This chapter reviews the current literature and describes in detail the 
background information of the project. Also, the challenges faced in previous 
studies are identified here.  
 
2.1. Background of Magnetism 
2.1.1. The classification of Magnetism 
 
   Magnetism is a property of materials that respond to an applied magnetic 
field. If a magnetic material is placed in an applied magnetic field of strength 
H, the individual atomic moments will contribute to an overall response 
known as magnetic induction, 
 
                        𝑩 = 𝜇0(𝑯 + 𝑴) ………………………….(2-1) 
 
where 𝝁𝟎 is the permeability of free space and the magnetization M = m/V  
is the magnetic moment per unit volume, where m is the magnetic moment on 
a volume V of the material. The most commonly seen magnetic materials are 
diamagnetism, paramagnetism, ferromagnetism, antiferromagnetism and 
ferrimagnetism in terms of magnetic behavior depending on their bulk 
magnetic susceptibility (χm). It is the degree of magnetization (M) of a material 





CHAPTER 2. LITERATURE REVIEW 
                                  
                            𝑴 = 𝝌𝒎𝑯…………………………......(2-2) 
 
In SI units χm is dimensionless and both M and H are expressed in Am−1. The 
atoms in diamagnetic material have no magnetic moments and no spontaneous 
magnetization. Also, the susceptibility of diamagnetic material is quite small 
and negative (-10-6 < χm < -10-3). In comparison, the atoms of paramagnetic 
material have magnetic moments that are randomly oriented and the 
susceptibility positive, but still small (10-5 < χm < 10-5) [11].  
 
 
Table 2-1. Type of Magnetism [11]. 
 
Ferromagnetic, antiferromagnetic, and ferrimagnetic are classified as magnetic 





CHAPTER 2. LITERATURE REVIEW 
magnetic moments align in one direction, showing very strong interactions 
even in the absence of a magnetic field. However, for a ferrimagnetic material, 
the magnetic structure is composed of two magnetic sublattices; A and B, 
separated by oxygen. Indirect or superexchange interactions mediated by the 
oxygen anions result in an antiparallel alignment of spins between the A and B 
sublattice where the magnetic moments are not equal and lead to a net 
magnetic moment. It shows all the hallmarks of ferromagnetic characteristics, 
spontaneous magnetization, hysteresis, remanence and Curie temperatures, but 
it has very different magnetic ordering. Magnetite is a well known 
ferrimagnetic material. [10].  
 
2.1.2. Soft and Hard Magnetic Materials 
 
   Magnetic materials can be also widely classified into two different types: 
soft magnetic materials and hard magnetic materials. Soft magnetic materials 
have a small coecivity (Hc), low magnetic anisotropy (Ku), high magnetic 
permeability and susceptibility so that they are easily magnetized or 
demagnetized exhibiting a small hysteresis cycle. Soft ferrites such as 
manganese ferrite, nickel ferrite and magnesium ferrite can be an example of 
soft magnetic materials. On the other hand, hard magnetic materials show high 
Hc, Ku, low magnetic permeability and susceptibility showing a large 
hysteresis cycle caused by the difficulty of demagnetization. Hard ferrites, 
aluminium-nickel-cobalt alloy and still can be examples of hard magnetic 
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2.1.3. Magnetic Nanoparticles 
 
   Magnetic nanoparticles are a class of nanoparticles which can be 
manipulated using magnetic field. The particles commonly consist of magnetic 
elements such as iron, nickel and cobalt and their chemical compounds. 
Nanoparticle usually refers to particles with a diameter smaller than 1 
micrometer (typically 5-500 nanometers) and those with diameters larger than 
micrometer (0.5-500 micrometer) refers to microbeads. Nowadays, magnetic 
nanoparticles have been received attention for bio-application owing to their 
attractive properties. First, their controllable size ranges from a few 
nanometers up to tens of nanometers, which means that they are smaller than 
or comparable to those of a cell (10–100μm), a virus (20–450 nm), a protein 
(5–50 nm) or a gene (2 nm wide and 10–100 nm long) enabling them not only 
to approach a biological entity of interest, but also to be coated with biological 
molecules for interacting with or binding to a biological entity [14]. Secondly, 
magnetic nanoparticles can be manipulated by external magnetic field 
gradients with the intrinsic penetrability into human tissue, opening up in 
guided transport/delivery of drugs and genes, as well as immobilization and 
separation of magnetically tagged biological entities [14, 15]. Thirdly, the 
magnetic nanoparticles resonantly respond to a time-varying magnetic field 
providing advantageous results. For instance, it transfers energy from exciting 
field to the nanoparticles. It enables magnetic nanoparticles injected into 
tumors to damage or necrotize the tumors by magnetically induced heating, 
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2.1.3-1. Unique Properties of Magnetic Nanoparticles 
   For ferromagnetic and ferrimagnetic materials, it exhibits irreversibility in 
the magnetization process with sweeping field, H called hysteresis. It leads to 
M-H curves called hysteresis loops. For magnetic nanoparticles, the shapes of 
hysteresis loops are related to particle size. For large particles (of the order >1 
micron), there is a multi-domain ground state which leads to a narrow 
hysteresis loop since it takes relatively little magnetic energy to move domain 
walls caused by low anisotropy due to the minimization of magnetic static 
energy in the multi domains. For small particles (in the 100s of nanometer 
range), there is a single domain ground state which leads to a broad hysteresis 
loop. Even smaller sizes (of the order of tens of nanometer or less) than a 
critical size of single domain, the particles undergo a magnetic transition from 
ferro- or ferrimagnetic particles to superparamagnetic in nature referring to 
superparamagnetism.  
 
Fig. 2-1. M–H curves are shown for the ferromagnetic (FM) injected particles, 
where the response can be either multi-domain (in FM diagram), single-
domain (in FM diagram) or superparamagnetic (SPM), depending on the size 
of the particle[17]. 
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reversed by thermal fluctuations, it exhibits zero Mr or Hc without an external 
magnetic field. However, it shows high magnetic moments under a net 
external field. This leads to the hysteretic, but still sigmoidal, M–H curve 
shown in Fig. 2-4 [17]. 
   The physics of superparamagnetism represented by an activation law for 
the relaxation time, τ of the net magnetization of the particle [18, 19]  
 
                 𝝉 = 𝝉𝟎 𝐞𝐞𝐞� Δ𝑬𝒌𝑩𝑻� …………………………….. (2-3) 
 
where ΔE is the energy barrier to moment reversal, and kBT is the thermal 
energy. 𝝉𝟎  is the relaxation factor. For non-interacting particles the pre-
exponential factor 𝝉𝟎 is of the order 10
−10~10−12s and only weakly dependent 
on temperature [19]. The energy barrier has several origins, including both 
intrinsic and extrinsic effects such as the magnetocrystalline and shape 
anisotropies, respectively; but in the simplest of cases it has a uniaxial form 
and is given by,  
 
                     𝑬 = 𝑲𝑲 ………………………………………. (2-4) 
 
where K is the anisotropy energy density and V is the particle volume. 𝑬 is 
the energy barrier to moment reversal or the amount of energy separating two 
energetically equivalent easy directions of magnetization. When 𝑘𝐵𝑇 >  𝐸𝑎, 
i.e. thermal energy (𝑘𝐵𝑇) exceeds the energy barrier (E), the magnetization is 
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2.1.4. Ferrite 
 
   Ferrites are usually non-conductive ferrimagnetic ceramic compounds 
derived from iron oxides such as hematite (Fe2O4) or magnetite (Fe3O4) as 
well as oxides of other metals. Ferrites are used in electronic inductors, 
transformers, and electromagnets due to the high electrical resistance leading 
to very low eddy current losses.  
 
2.1.4-1. Spinel Ferrite 
 
Fig. 2-2. The spinel Structure (Closed-packed spheres)[12] 
 
   The general chemical formula of ferrites that have the spinel structure (i.e. 
the same structure as the mineral spinel MgAl2O4) is MFe2O4, where M is a 
divalent metal ion. M is usually a transition metal such as Mn, Fe, Co, Ni or 
Cu, or Zn Mg or Cd, which is widely used for various applications. It is also 
possible to make ferrimagnetic spinels that are solid solutions of two or more 
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for M to be a mixture of ions that have an average valence of 2.  
   The spinel structure is shown in Fig. 2-1. The relatively large oxygen ions 
(Anion X) form an fcc lattice where there are 32 octahedral sites (i.e. sites 
surrounded by 6 oxygen ions) and 64 tetrahedral sites (surrounded by 4 
oxygen ions). However, in the spinel structure only 8 of the tetrahedral sites 
and 16 of the octahedral sites are occupied by metal ions. These tetrahedral 
and octahedral sites are referred to as A and B sites respectively (Fig. 2-2) [13].  
 
 
Fig. 2-3. Arrangements of metal ions in the two octants A and B, showing 
tetrahedrally (A) and octahefrally (B) coordinated sites[13]. 
 
 
2.1.4-2. Types of Spinel 
 
   Three different types of spinels are determined by the preference of cation 
occupancy for A and B-sites. A normal spinel has its A-sites occupied by metal 
M2+ cations and its B-sites occupied by Fe3+ ions. For inverse spinel, the A-
sites are occupied by Fe3+ ions and B-sites are randomly occupied by M2+ and 
Fe3+ cations. If A and B-sites both contain a fraction of M2+ and Fe3+ cations, 
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Fig. 2-4. Magnetic structures of normal and inverse spinels (a) normal 
manganese ferrite, Mn Fe2O4 (b) inverse nickel ferrite, NiFe2O4 (c) normal 
zinc ferrite, ZnFe2O4 [12]. 
 
   The ferrites MnFe2O4, ZnFe2O4 and CdFe2O4 are known as normal spinels 
because the divalent ions Mn2+, Zn2+ and Cd2+ ions occupy tetrahedral A sites. 
This distinction between normal and inverse spinels is not rigid, since there 
are many examples where ions of a particular species can be found on both A 
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composition, preparation conditions and heat treatment [12].  
 
2.2. Hyperthermia  
2.2.1. History of Hyperthermia  
 
   Hyperthermia as a treatment of cancer has been recorded since ancient 
times. A fire stick was used to burn away a breast tumor by an Egyptian and 
Induced fevers were shown to aid in the treatment of cancers in the late 19th 
century. The hot metals and burning lenses were also used in cancer treatment 
until the 19th century. After the early 20th century, high frequency currents 
could generate in-depth heating of tissues. For instance, thermotherapy using 
RF power, hot water coils and microwave became popular throughout the 
1930s - 1950s. Even though some techniques such as chemotherapy and 
radiotherapy have improved in the 1950s, there had been less interest in 
hyperthermia therapy until 1970s which saw a resurgence in research into 
hyperthermia [20].  
   Nowadays, hyperthermia techniques such as whole body, regional and 
local hyperthermia are used in conjunction with other cancer treatment 
modalities because they have been found to enhance the effectiveness of 
radiation and some chemotherapeutic drugs [21]. However, there is still the 
difficulty of heating a local tumor region to the desired temperature without 
significant damage to normal tissue. Thus, the development of novel 
hyperthermia systems that are able to heat tumor cells above 43°C without 
damaging normal tissues is required. Magnetic nanoparticle mediated 
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application, which has the potential to overcome these drawbacks.   
 
2.2.2. Hyperthermia Methods  
 
   There are 2 main ways in which hyperthermia can be used: Firstly, very 
high temperatures are used to kill the cancer cells, coagulate the proteins, and 
destroy the blood vessels.  In effect, the area is exposed to the heat by radio 
waves, microwaves, ultrasound waves, and other forms of energy. This is often 
called local hyperthermia or thermal ablation. 
   Secondly, the temperature of a part of the body (or even the whole body) 
can be raised to a higher than normal level. It is not hot enough to kill the cells 
directly, but this can allow other types of cancer treatments such as radiation 
therapy, immunotherapy, or chemotherapy to work better. This is known as 
regional hyperthermia or whole-body hyperthermia [22]. 
 
2.2.3. Side Effects of Hyperthermia 
 
   Regional or local hyperthermia can lead to pain at the site, swelling, 
infection, bleeding, blistering, blood clots, burns, and damage to the skin, 
nerves, and muscles near the treated area. For whole-body hyperthermia, it can 
give rise to nausea, vomiting, and diarrhea. More serious side effects can 
include problems with the heart, blood vessels, and other major organs, though 
rare. Experience, improved technology, and better skills in using hyperthermia 
treatment have led to fewer side effects. In most cases, the problems that 
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2.2.4. Future of Hyperthermia 
 
   Even though hyperthermia is considered as a promising way to improve 
cancer treatment, it is largely an experimental technique at this time and is not 
commonly used. Many clinical trials of hyperthermia are being done to better 
understand and improve this technique. For instance, the induction heating of 
magnetic materials, the use of nanoparticles that are implanted into tumors are 
some new types of hyperthermia that are under study. And researchers 
continue to look at how hyperthermia is best used along with other cancer 
treatments to improve outcomes [22]. 
 
2.3. Magnetic Hyperthermia  
 
   Magnetic heat induction of magnetic nanoparticles provides various 
advantages over conventional hyperthermia treatment. Firstly, magnetic 
nanoparticles have the sizes ranging from a few tens of nanometers, and hence 
are easily absorbed by tumor cells, which enhances the effectiveness of 
delivering heat specifically to targeted tissue regions [23]. Second, the 
magnetic fields in the harmless range to human body are used [24]. Thirdly, 
magnetic nanoparticles can effectively cross the blood-brain-barrier, opening 
up a new modality of treatment for brain tumors [25]. Fourthly, magnetic 
nanoparticles can be easily manipulated in a colloidal form with numerous 
drug delivery methods [26]. Finally, it can be functionalized for controlled 
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a number of diseases [27].   
   Based on this context, local hyperthermia using magnetic nanoparticles has 
been considered to be a promising therapeutic modality of cancer treatment in 
nanomedicine [5, 28].  
 
2.3.1. Magnetic Fluidic Hyperthermia 
 
   The application of magnetic fluidic hyperthermia treatment was 
investigated in the work of Chan et al. [29] and Jordan et al. [30] in 1993. The 
high efficiency of a superparamagnetic suspension could absorb the energy 
from alternating magnetic field and convert into heat generation, which was 
experimentally demonstrated in these studies. Since tumor cells are sensitive 
to high temperature than normal cells, increasing the temperature of tumor 
tissue in vivo enables to destroy the pathological cells [28, 31]. Developing 
nanotechnology has contributed to the improvement of magnetic fluid 
hyperthermia for a few decades. This is a promising method for cancer 
treatment owing to ease in targeting the cancerous tissue with fewer side 
effects than radiotherapy and chemotherapy. The results of current/ongoing 
clinical trials show significant reduction in side effects [30]. They injected 100 
mg dextran magnetite into the tail vein of Sprague–Dawley rats, treated with 
AC magnetic field (12 min, 450 kHz, unknown field and SAR), and saw tumor 
shrinkage and tissue necrosis [31].  
   Rand et al. introduced additional radiofrequency heating up to more than 
55 °C on the renal surface of rabbits. In this way, total coagulation necrosis of 
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hyperthermia treatment than caused by the occlusion [34, 35].  
   The first clinical patient trials [33] used a hyperthermia-generating 
prototype instrument which is able to generate variable magnetic fields in the 
range of 0–15 kA/m at a frequency of 100 kHz. The machine also enables to 
measure the temperature of patient in real time so an examiner ensures 
whether therapeutic temperature threshold is exceeded or not [36-49].  
   Currently, only local hyperthermia is considered for magnetic fluid 
hyperthermia. For this purpose, magnetic nanoparticles in a carrier fluid are 
placed inside the tumor through direct injection or tumor specific antibody 
targeting, after which the tumor is exposed to an alternating magnetic field. 
This field makes the particles generate heat by magnetic relaxation 
mechanisms.  
   For hyperthermia treatments knowing the temperature profile obtained in 
the tissues is of utmost importance. The ideal temperature profile is one where 
the body temperature in healthy tissue is maintained, while the therapeutic 
temperature of 45 °C inside the tumor is reached immediately and maintained 
constant. In reality these temperature profiles are not flat, neither in the tumor 
nor in normal tissue, because of thermal diffusion. 
 
2.3.2. Heating Mechanisms 
2.3.2-1. Hysteresis Loss 
 
   Ferromagnetic nanoparticles generate heating by hysteresis loss 
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dominantly contributes to the Ptotal (total heating power). Physteresis loss can be 
expressed by 
 
        𝑷𝒉𝒉𝒉𝒉𝒉𝒉𝒉𝒉𝒉𝒉 𝒍𝒍𝒉𝒉 = 𝝁𝟎𝒇∮𝑯𝑫𝑫,𝒂𝒂𝒂𝒍 ∙ 𝒅𝑴 = 𝝁𝟎𝒇𝒇…………..(2-5) 
  
where, μ0 is the permeability of free space (4π x 10-7 H/m), f is the frequency 
of the applied magnetic field, HDC,appl is the intensity of DC magnetic field, M 
is the magnetization and A is the area of hysteresis loop. Total heating is 
proportional to the frequency of the applied field and the area of the magnetic 
hysteresis loop.  
 
2.3.2-2. Relaxation Loss 
 
   Superparamagnetic nanoparticles show two different kinds of heat 
generating mechanism, Néel relaxation and Brown relaxation mechanism. The 
Néel relaxation mechanism is characterized by the rotation of the magnetic 
spin moment. In this case, the magnetic anisotropy energy barrier of the 
superparamagnetic nanoparticles needs to be overcome before the reversal of 
the magnetization of the superparamagnetic nanoparticles can occur. Thus, the 
intrinsic anisotropy (material, surface, shape etc.) and the volume of the 
superparamagnetic nanoparticles affect the Néel relaxation time and hence the 
heating efficiency of the superparamagnetic nanoparticles. The formula for the 
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                       𝝉𝑵 =  (𝝉𝟎𝒉𝑲𝑲𝒎𝒌𝑩𝑻 ) …………………………. (2-6) 
 
where 𝜏0 is the relaxation factor, K is the magnetic anisotropy energy density, 
𝑉𝑚 is the mean particle volume, kB is the Boltzmann constant, and T is the 
absolute temperature.  
   The Brownian relaxation mechanism is characterized by the rotational 
Brownian motion of nanoparticle itself. In this case, the energy barrier is 
determined by the rotational friction within the medium. The viscosity of the 
physiological medium it is immersed in and the hydrodynamic diameter 
(nanoparticle core diameter plus any capping) will then influence the 
Brownian relaxation time and hence heating efficiency. Thus, the formula for 
the Brownian relaxation time constant is 
 
                         𝝉𝑩 =  𝟑𝟑𝑲𝑯𝒌𝑩𝑻  …………………..…….. (2-7) 
 
where 𝜂 is the viscosity of the medium, 𝑉𝐻is the hydrodynamic volume of the 
particle, kB is the Boltzmann constant and T is the absolute temperature. 
   In the general case, the faster of the relaxation mechanisms is dominant 
(i.e. shorter time constant) and the effective relaxation time when both 
relaxation mechanisms take place in parallel is 
  









 ……………………….. (2-8) 
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   For small field amplitudes, and assuming minimal interactions between the 
constituent superparamagnetic nanoparticles, the imaginary part χm” of 
magnetic susceptibility χm is related to magnetic losses. The volumetric power 
dissipation P is related to χm” according to the following equation: 
 
                  𝑷 =  𝝁𝟎𝝅𝝌𝒎” 𝑯𝟐𝒇 …………………………….… (2-9) 
 
where 𝜒𝑚”  is the out-of-phase magnetic susceptibility, 𝐻 is the amplitude of 
the magnetic field and 𝑓 is the frequency of the field applied. This equation 
can be interpreted physically as, if the magnetization M lags H, there is a 
positive conversion of magnetic energy into internal energy. In the framework 
of a linear response function, M = χmH and where χm is expressed as a complex 
number, 𝜒𝑚 = 𝜒𝑚′ − 𝑖𝜒𝑚”  , where 𝜒𝑚” becomes the loss component of 
magnetic susceptibility.  
 
2.3.3. Specific Loss Power (SLP) 
 
   Specific Loss Power (SLP) is useful for comparison with the heat 
generating performance of magnetic nanoparticles. The heating capacity of 
magnetic nanoparticles is given by the SLP: 
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and dispersion medium, ∆𝑇
∆𝑡
: change in temperature with respect to time (or 
slope of the time-dependent temperature curve), 𝑚𝑓𝑓𝑓𝑓𝑖𝑡𝑓: mass of the ferrite. 
 
2.4. Targeting Liver Tumors with Hyperthermia using Ferrimagnetic 
Nanoparticle 
 
2.4.1. Liver Cancer 
 
   Hepatocellular carcinoma (HCC), or primary liver cancer, accounts for 80% 
- 90% of all liver cancers. The cause of liver cancer is unknown, but 
contributing factors include chronic liver disease, viral hepatitis, carcinogens, 
and food toxins. Fig. 2.5 shows the blood supply to the liver and hepatic tumor 
[51]. The tumor receives 95% of its blood supply from the hepatic artery, 
while the normal liver tissue receives 75% of its blood supply from the portal 
vein and the rest from the hepatic artery.  
 
Fig. 2-5. Blood supply to the liver and hepatic tumor. The large, blue vessel is 
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2.4.2. Treatment of Liver Cancer  
 
   Surgical resection or liver transplants are the optimal treatment options, 
but for the 85%-90% of patients who are not eligible for this treatment 
prognosis is poor and there is a need for alternative curative and palliative 
treatments. New forms of local treatment are available, but large tumors are 
still difficult to treat [51]. The differential in blood supply between hepatic 
tumors and normal hepatic parenchyma (NHP) has been successfully exploited 
in treatment modalities such as Hepatic Arterial Chemotherapy (HAC), 
Selective Internal Radiotherapy (SIRT) and Transcatheter Arterial 
Chemoembolization (TACE), which target liver tumors with chemotherapeutic 
agents and radiation (Burton et al. 1989; Ho et al. 1998; Kemeny et al. 1999; 
Campbell et al. 2000). However, chemotherapy and radiotherapy were limited 
by side effects such as poor survival rates of patients. Therefore, the 
development of targeted hyperthermia as a treatment is appealing because it 
allows for a greater number of repeated localized treatments without limitation 
by the accumulation of toxic side effects.   
 
2.4.3. Arterial Embolization Hyperthermia (AEH) 
 
   Due to the advantage of the treatment using ferrimagnetic nanoparticles 
such as the availability of selective treatment and combined with other 
treatment, it has been studied for the past two decades as a local hyperthermia 
agent for liver cancer [1, 2, 52].  
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hyperthermia. It consists of the selective arterial embolization of liver tumors 
with ferrimagnetic particles, followed by applied AC magnetic field to 
generate hysteretic heating of the embolized particles.  
   Mitsumori et al. and Jones et al reported significant tumor response using 
this technique. Paul Moroz et al. studied for hyperthermia targeted liver 
tumors (hepatic VX2 carcinomas) with ferromagnetic embolization in a rabbit 
liver tumor model. Magnetic iron oxide particles (Fe2O3, 100-200 nm) were 
suspended in lipiodol, which was catheterized the cystic artery of a rabbit [1]. 
This study has demonstrated that hepatic arterial infusion of ferromagnetic 
particles suspended in lipiodol results in excellent tumor targeting. However, 
due to a large particle size (>150 nm) and a lower heating characteristic, 
higher applied magnetic field (Happ = 376 Oe) at the frequency (fapp=53 kHz) 
and a large amount of nanoparticles (100 mg) were required, causing the 
aggregation of the nanoparticle agents during intra-arterial injection. Therefore, 
the development of a newly designed ferrimagnetic nanoparticle agent, which 
has a smaller particle size, a size distribution as well as exhibits a high specific 
loss power (SLP), is urgently required for inter-arterial hyperthermia modality.     
 
2.5. Synthesis of Magnetic Nanoparticles 
 
   Magnetic nanoparticles are a promising material for biomedical 
applications as mentioned above. Naturally, the synthesis of magnetic 
nanoparticles with controlled-size and a high degree of monodispersity has 
been an interest of the scientific and engineering fields [53]. Over a few 
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magnetic nanoparticles from physical methods to chemical methods. Due to 
the advantages in controlling particle size distribution, crystallinity and 
dispersity, the chemical methods such as co-precipitation, microemulsions, 
high temperature thermal decomposition (HTTD), and sol gel techniques are 
more suitable than physical methods for biomedical applications such as 
magnetic resonance imaging (MRI) and hyperthermia.   
 
Co-precipitation 
   Co-precipitation is a simple and convenient approach to synthesis iron 
oxides from simultaneous precipitation of Fe2+/Fe3+ ions in basic aqueous 
media [54,55]. Generally, the co-precipitation technique involves the complex 
hydrolysis equilibria of ferric and ferrous ions. The size, shape, and quality of 
the synthesized magnetic nanoparticles depends largely on a large number of 
synthetic parameters such as the type of salts used (e.g. chlorides, sulfates, 
nitrates), the Fe2+/Fe3+ ratio, the reaction temperature, the pH value and ionic 
strength of the media. They are difficult to control and require careful 
adjustments during the experiment [53, 56, 57]. As particles prepared by co-
precipitation are unfortunately difficult to control, this method tends to yield 
particles with a broad size distribution of greater than 50% [58]. Despite the 
intrinsic problems such as large polydispersity, broad size distribution and low 
degrees of crystallinity, this approach is well-documented and allows mass 
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   Water-in-oil (W/O) microemulsions (i.e. reverse micelle solutions) are 
transparent, isotropic, thermodynamically stable liquid media. In these 
systems, fine microdroplets of the aqueous phase are trapped within 
assemblies of surfactant molecules dispersed in a continuous oil phase. The 
surfactant-stabilized microcavities (typically in the range of 10 nm) provide a 
confinement effect that limits particle nucleation, growth, and agglomeration 
[61]. This microemulsion method offers the advantage over the co-precipation 
method for producing nanoparticles with better size control, but results in 
complicated purifying procedures to remove surfactants, low yield and is 
difficult to scale up.  
 
High Temperature Thermal Decomposition (HTTD) 
   This procedure involves the high temperature thermal decomposition of 
organometallic precursors in high boiling organic solvents in the presence of 
stabilizing surfactant molecules that regulate the nucleation and growth 
kinetics of the particles. In principle, the ratios of the starting reagents (such as 
organometallic compounds, surfactant and solvent), the reaction temperature, 
reaction time, and aging period are critical parameters for the control of the 
size and morphology of magnetic nanoparticles [60]. High quality samples, in 
terms of crystallinity and size dispersion, can be produced in reasonable 
amounts, and the approach can be scaled up [59]. As a result, HTTD is a 
popular and efficient method that is used for nanoparticle synthesis. It 
provides good particle size control, monodisperse particles, high degree of 
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2.6. Synthesis of MFe2O4  
 
   Sun et al. found the synthesis monodispersed MFe2O4 (M=Fe,Co,Mn) 
nanoparticles by simply changing the metal acetylacetonate precursor that is 
to be added to the mixture of Fe(acac)3 and 1,2-hexadecanediol [53]. They 
also found that higher reaction temperatures cause larger particle size as well 
as they introduce a surface manipulation step (by mixing with a bipolar 
surfactant, tetramethylammonium 11-aminoundecanoate) to make them 
water-soluble.  
   MgFe2O4 nanoparticles have been synthesized by many groups with 
various ways. However, a few groups have dealt with MgFe2O4 nanoparticles 
as hyperthermia agents. Maehara et al. studied the heating of MgFe2O4 powder 
by an AC magnetic field (fapp=370 khz, Happ=400 A/m ≒ 5 Oe) for thermal 
coagulation therapy. The size of the MgFe2O4 purchased from Kojundo 
Chemical Laboratory Co. Ltd were 2~10 um (99.9%) and the heating ability in 
the AC magnetic field was 1.4 W/g [4].  
   Asahi Tomitaka et al. studied evaluation of magnetic and thermal 
properties of ferrite nanoparticles including MgFe2O4 by an AC magnetic field 
(fapp=10 khz, Happ= 50 ~ 500 Oe). The size of the MgFe2O4 were 27.4 ±9.2 nm, 
34.4 ±16.1 nm, 130.2 ±40.7 nm synthesized by sol-gel method demonstrating 
that the optimum field strength of the MgFe2O4 is 100 – 150 Oe and MgFe2O4 
nanoparticles are not suitable for biomedical application due to their low 
magnetization. However, it showed high viability of human cervical 









3.1. Sol-gel Method 
 
   The sol-gel method is a wet-chemical technique and widely used in the 
fields of material science and ceramic engineering. In this process, the sol 
evolves gradually towards the formation of a gel- like network containing both 
a liquid phase and a solid phase. The basic structure or morphology of the 
solid phase can range anywhere from discrete colloidal particles to continuous 
chain-like polymer networks. It also is an efficient method for preparing 
nanomaterials, and it enables high yield and more promising results of the 
synthesis of ultra fine particles with good chemical homogeneity, high purity 
at a fairly low temperature [62, 63].  
   In this work, the conventional sol-gel method that included only sintering 
process was used for the synthesis of ferrimagnetic MFe2O4 (M=Co, Ni, Mg) 
nanoparticles. However, a modified sol-gel method, consisted of calcining 
process, ball milling process and sintering process, was used for the synthesis 
of modified ferrimagnetic MgFe2O4 nanoparticles. 
    
3.2. Preparation of Synthesis 
3.2.1. Equipment 
 
   Fig. 3-1(a) shows sol-gel systems that consist of three neck round bottom 
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It was used for sol-gel formation. The liquid temperature inside three neck 
round bottom flask was measured by TECPEL digital thermometer (Fig. 3-
1(d)). Digital analytical balance was used for the weight of powders.  
 
    
 
Fig. 3-1. (a) Sol-gel Systems (b) Three neck round bottom flask and magnetic 
stirrer bar (c) Corning hot-plate/magnetic stirrer (d)TECPEL digital 
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Fig. 3-2. (a) Natural Convection Oven (b) Mortar and Pestle (c) Crucible (d) 
Program Muffle Furnaces 
 
   A natural convection oven for removing unnecessary chemicals, mortar 
and pestle for grinding, crucible and program muffle furnaces for baking, were 
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3.2.2. Chemical and Reagents 
 
   The chemicals and reagents were required for the synthesis of 
ferrimagnetic MFe2O4 (M=Co, Ni, Mg) nanoparticles using the sol-gel 
methods.  
   First, Iron (III) nitrate nonahydrate (98+%) was used as a metal precursor, 
providing Fe3+ ions, which is highly soluble in organic solvents. Magnesium 
(II) acetate tetrahydrate, in the form of powder, contributed to the required 
Mg2+ ions for magnesium ferrite formation. For nickel ferrite formation, 
Nickel (II) acetate tetrahydrate, in the form of powder, was used for the 
required Ni2+ ions. Cobalt (II) acetate tetrahydrate, in the form of powder, 
contributed to the required Co2+ ions for cobalt ferrite formation. Fig. 3-3 
shows the picture of powders from Sigma-Aldrich and Table 3-1 shows the 




Fig. 3-3. Reactants used in the sol-gel methods (From left: Iron (III) nitrate 
nonahydrate, Magnesium acetate tetrahydrate, Cobalt (II) acetate 
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Name of Reagents 
Chemical 
Formula 
Linear Formula Molecular Weight 
Iron (III) nitrate 
nonahydrate 
(98+%) 






Mg · 4H2O 
214.4 
Nickel  (II) acetate
  tetrahydrate 
(99.998%)  
Ni (OCOCH3)2
 · 4H2O 
248.84 




 · 4H2O 
249.08 
 
Table 3-1. Name, chemical formula and molecular weight of compounds used 





















HOCH2 CH2OH 62.07 
 
Table 3-2. Name, Chemical Formula and Molecular Weight of additional 
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   Secondly, three other chemicals; Acetic acid, 2 Methoxyethanol and 
Ethylene Glycol were also necessary for the sol-gel methods. Acetic acid 
serves as a catalyst increasing the rate of hydrolysis. 2-Methoxyethanol serves 
as solvent. Finally, ethylene glycol serves as a precursor to polymers. The 
chemical formula and molecular weight of chemicals are shown in Table 3-2.  
 
 
3.3. Synthesis Procedure using Modified Sol-gel Method 
 
   The experimental procedure of modified sol-gel method consists of three 
stages. The first stage is the preparatory stage, which is the preparation of the 
reagents/chemicals to be added and mixed together in the three neck round 
bottomed flask. The second stage is heating and stirring of the mixture for sol 
and gel formation using magnetic stirrer/hot plate. The final stage is to control 
temperature of furnace for the formation of nucleation and growth of magnetic 
nanoparticles using the program muffle furnaces. 
 
3.3.1. Preparatory Stage 
 
   A stoichiometric molar proportion (8 mmol/ 4 mmol) of iron(III) nitrate 
nonahydrate [Fe(NO3 )3 ·9H2O] (3.308 g) and magnesium acetate tetrahydrate 
[Mg(CH3CO2)2 ·4H2O] (0.874 g), were used as a metallic powder precursor 
for MgFe2O4. For NiFe2O4 and CoFe2O4, [Ni(CH3CO2)2 ·4H2O] (1.014 g) and 
[Co(CH3CO2)2 ·4H2O] (1.015 g) were used, respectively. These starting 
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stirring on the hot plate/magnetic stirrer.  
 
3.3.2. Sol-gel Formation Stage 
 
   The starting materials and ethyl alcohol were well mixed in the three neck 
flask. After 10 minutes, 1 ml of acetic acid was slowly added as a catalyst, 
which increases the rate of hydrolysis. After 20 minutes, 2-methoxyethanol (2-
MOE) was slowly added as a solvent. As can be seen in Fig. 3-4, the rest of 
chemicals including H2O, ethylene glycol, ethyl alcohol were added together 
during heating and stirring process until the solutions became a gel states. The 
chemically synthesized gelatin state stock solutions by the metallic powder 
precursor and the solvent were dried at 100 ˚C in oven to remove the chemical 
binders.  
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3.3.3. Baking Stage 
3.3.3-1. Controlling Calcining Temperature 
 
   The modified sol-gel method includes this calcining process. However, the 
conventional sol-gel method does not include this calcining process. After 1 
day, the dried sample was well ground using mortar and pestle (Fig. 3-2 (b)) 
then, it put into the crucible (Fig. 3-2 (c)) and it was calcined at temperatures 
(400 ˚C, 500 ˚C and, 600 ˚C), respectively for 1 hour using programmable 
muffle furnaces (Fig. 3-2 (d)). After finishing completing the calcining process, 
the sample was well ground by using mortar and pestle.   
 
 
Fig. 3-5.Change in calcining temperature of modified sol-gel method 
 
3.3.3-2. Ball Milling Process 
 
   The well-ground samples from the calcining process were put into a mill 
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factor because it influences the trajectory of the balls and mechanical energy 
supplied to the powder. Defining the critical speed of rotation as the speed 
required to take the balls to the apex of revolution, the critical speed can be 
defined as, 
 
               𝑻𝒉𝒉 𝒄𝒉𝒉𝒉𝒉𝒄𝒂𝒍 𝒉𝒂𝒉𝒉𝒅 = ( 𝒈
𝒉
 )𝟏 𝟐⁄ 𝟐𝝅⁄ ……..….(3-1) 
 
, where r is the radius of the mill and g is the acceleration due to gravity. In 
practic, ball mills are operated at ~75% of the critical speed so that the balls do 
not reach the top of the mill (Fig. 3-6).  
                                  
Fig. 3-6. Schematic of a ball mill in cataracting motion 
 
   In addition, the ball milling process does not lend itself easily to rigorous 
theoretical analysis so empirical relationship of rate of milling can be defined 
as, 
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, where A is numerical constant that is specific to the mill being used and the 
powder being, a is the radius of the mill, 𝝆 is the density of the balls, d is the 
particle size of the powder, and r is the radius of the balls. Based on this 
equation, the change in the size of balls (diameter : 3 mm and 5 mm) keeping 
the rate of milling with other experimental conditions, resulted in the change 
in the size of nanoparticles. The milling time was limited within 6 hours to 
avoid undesired side effect such as induced heating. For 6 hours, the induced 
heating was less than 3 °C.   
 
 
Fig. 3-7.Change in ball milling process of modified sol-gel method 
 
   The information of Al2O3 balls that was used is shown in table 3-3. Based 
on the information which was calculated by theoretical equation, the weight 
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Table 3-3. The specification of Al2O3 balls 
 
3.3.3-3. Controlling Sintering Temperature 
 
   After ball milling process, the samples put into programmable muffle 
furnaces and they were sintered at the temperatures (700 ˚C, 750 ˚C, 800 ˚C, 
850 ˚C and, 900 ˚C). Then, the nanoparticles (in powder form) were ground by 
using mortar and pestle. This concludes the synthesis of magnetic 
nanoparticles.  
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3.4. Characteristics Measurement 
 
3.4.1. X-ray Diffractometer (XRD) 
 
Fig. 3-9. Schematic Diagram of X-Ray Diffractometer [66]. 
 
   The crystal structure of the magnetic nanoparticles was measured by 
Siemens Powder X-ray Diffractometer with CuKα radiation. X-ray diffraction 
is quite a common technique for the study of atomic spacing and crystal 
structures.The monochromatic X-ray generated by a cathode ray tube and 
filtered, are collimated to concentration, and directed toward the substance. 
When Bragg`s Law (nλ=2d sin θ) that relates the wavelength of 
electromagnetic radiation to the diffraction angle and the lattice spacing in a 
crystalline sample, is satisfied, the interaction of the incident rays with the 
sample produces constructive interference. Then, the diffracted X-rays are 
detected, processed and counted (Fig. 3-9).  
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rotates to various 2θ angles to measure diffraction from the sample [66]. 
Conversion of the diffraction peaks to d-spacing enables identification of the 
substance because each substance has a set of unique d-spacing. Normally, it is 
achieved by comparison of d-spacing with standard reference patterns [65]. 
Also, the lattice parameter a, can be determined from the following equation: 
 
              𝒅𝒉𝒌𝒍 = 𝒂�𝒉𝟐+𝒌𝟐+𝒍𝟐 ................................................(3-3) 
 
where dhkl is the interplanar spacing and hkl are the Miller indices.  
 
 3.4.2. Field Emission Scanning Electron Microscopy (FE-SEM) 
 
   The mean size and size distribution of the magnetic nanoparticles were 
measured by FE-SEM (JSM series). A FE-SEM is a microscope that works 
with electrons that are liberated by a field emission source. The object is 
scanned by electrons according to a zig-zag pattern. The field emission 
cathode in the electron gun provides narrower probing beams at low as well as 
high electron energy, resulting in both improved spatial resolution and 
minimized sample charging and damage. The electrons generated by a field 
emission source are accelerated in a field gradient,  
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smaller tip enables a larger field and more electrons. The electrons can be 
focused by magnetic lenses (Fig. 3-10). Furthermore, an accelerated electron 
excites a secondary electron from another atom and the secondary electrons 
that are released from a depth of 1-5 nm can be detected by FE-SEM. Raised 
areas of a sample will produce more secondary electrons and appear as bright 
spots in the image compared to trenches and valleys, which will appear as dark 
spots [67].  
 
.  
Fig. 3-10. FE-SEM Principle [67] 
 
 
 3.4.3. Vibrating Sampled Magnetometer (VSM) 
 
   The magnetic characteristics of the synthesized nanoparticles including 
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and initial M-H loop were measured by VSM of Lake Shore 7400 series (Lake 
Shore Cryotronics, Inc) in order to investigate their dependence on the 
synthesis condition.   
   The principle of VSM is to measure the electromotive force induced by the 
rotating magnetic sample with a constant frequency under the presence of a 
static and uniform magnetic field. According to Faraday’s Law, the 
electromotive force induced in the sensing coil is: 
 
                        𝑲𝒉𝒎𝒇 = −𝒅𝒅𝒅𝒉  ………………………… (3-6) 
 
Where 𝒅 is the magnetic flux and t is time. The magnetic induction B inside 
of a solenoid coil of cross-sectional area A consisting of N turns is,    
 




From equation 3.6 and 3.7, we can get the equation,  
 
                       𝑲𝒉𝒎𝒇 = −𝑵𝒇𝒅𝑩𝒅𝒉…………..…………. (3-8) 
 
The magnetic moment of the sample may be written as 
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where f is the frequency at which it is vibrating and m0 is the amplitude of the 
magnetic moment. Since 𝑩 = 𝝁𝟎𝑯 + 𝑴, where the volume magnetization 
𝑴 = 𝒎
𝑲
, H is constant, 
 




𝒄𝒍𝒉 (𝒇𝒉) …………………………….(3-10) 
 
Substituting equation 3.10 into 3.8, we obtained, 
 
          𝑲𝒉𝒎𝒇 = −𝑵𝒇(𝒎𝟎𝒇𝑲 )𝒄𝒍𝒉 (𝒇𝒉) ………………………. (3-11) 
 
                𝑲𝒉𝒎𝒇 = 𝒎𝟎𝒇𝒇𝑺 ……………………………..(3-12) 
 
where, 𝑲𝒉𝒎𝒇 is voltage induced in the coils, m0 is magnetic moment, A is 
amplitude of vibration (1.4mm), f is frequency of vibration (82 Hz) and S is 
sensitivity function of the coils [70]. 
   The schematic diagram of detection-coil arrangement and picture of VSM 
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3.4.4. Frequency & Magnetic field tunable AC inductive coil-capacitor 
system 
 
   A specially designed frequency and magnetic field tunable AC inductive 
coil-capacitor system (Fig. 3-12) is composed of a wave generator, a high 
frequency amplifier, and magnetic induction coils. AC magnetic-field-induced 
heating temperature (Tac,mag) of magnetic nanoparticle both in a solid and 
liquid were measured using this system in the range of magnetic field (Happl = 
140 Oe) and frequency (fappl = 110 kHz) that were fixed for the measurement 
in the biologically tolerable ranges of magnetic field.   
 
 




3.4.5. Dynamic Light Scattering (DLS) 
 
   A Zetasizer Nano ZS Dynamic Light Scattering by Malvern Instrument 
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the nanoparticles. For the consistent preparation, the same amount of 
nanoparticles (Powder) was prepared for coating process and it was conducted 
by same coating condition. After that, the concentration of coated 
nanoparticles was measured by VSM. All samples were diluted as 0.1 mg/ml 
(The minimum concentration for the samples in the range of diameter from 0.3 
nm to 10 um). It filled into a specific unique cell for the Zetasizer Nano ZS. 
The machine shows the mean values after measuring more than ten times. 
   Dynamic Light Scattering (Photon Correlation Spectroscopy) measures 
Brownian motion that relates to the size of the particles by illuminating the 
particles with a laser and analyzing the intensity fluctuations in the scattered 
light. If a small particle is illuminated by a light source, light is scattered by 
the particle in all directions. Then, the screen that is held close to the particle 
will be illuminated by the scattered light. The screen would show a speckle 
pattern that will consist of areas of bright light and dark areas where no light is 
detected [71].  
   The diagram below shows the propagated waves from the light scattered 
by the particles in Fig. 3-13(a). The bright areas are the light that are scattered 
by the particles arrived at the screen with the same phase and interferes. On 
the other hand, the dark areas are where the phase additions are mutually 
destructive and cancel each other out.  
   The particles are continuously moving due to Brownian motion due to the 
random collision with the molecules of the liquid. The relationship between 
the size of a particle and its speed due to Brownian motion is defined in the 
Stokes-Einstein equation (Eq. 3.13). The diffusion of spherical particles 
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,where kB is the Boltzmann constant, and T is the absolute temperature, r is the 
radius of the spherical particle and 𝜂 is viscosity.   
   As the particles are constantly in motion the speckle pattern will also 
appear to move. As the particles move around, the constructive and destructive 
phase addition of the scattered light will cause the bright and dark areas to 
grow and diminish in intensity - or to put it another way, the intensity appears 
to fluctuate. The Zetasizer Nano system measures the rate of the intensity 
fluctuation and then uses this to calculate the size of the particles [71]. 
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CHAPTER 4 
RESULTS & DISCUSSION 
 
4.1. Ferrimagnetic MFe2O4 (M=Co, Ni, Mg) Nanoparticles 
 
   Ferrimagnetic MFe2O4 (Ni, Mg, Co) nanoparticles were synthesized by 
conventional sol gel method to investigate and compare the feasibility for an 
intra arterial hyperthermia agent. In order to evaluate and compare AC heat 
generation ability of the synthesized ferrimagnetic nanoparticles that had the 
size range of 30~40 nm, TAC,mag (AC magnetically induced heating 
temperature) in solid state was measured. The cytotoxicity using the normal 
rat liver epidermal cells was also investigated to estimate the bio-feasibility to 
hyperthermia agent applications.   
 
4.1.1. Physical Properties of Ferrimagnetic MFe2O4 (M=Ni, Co and Mg) 
Nanoparticles 
 
   The mean particle size and the size distribution of ferrimagnetic MFe2O4 
(M=Ni, Co and Mg) nanoparticles determined by an FE-SEM are shown in 
Fig. 4-1. The mean particle size (diameter) and the size distribution were 
measured by the FE-SEM image. The size of all nanoparticles on the image 
were measured based on the scale bar on the image. Then, mean value was 
calculated. The error was calculated based on standard deviation (σ) showing 
how much variation or “dispersion” exist from the mean. 
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(30.3 nm ±7.2 nm) had a round shape and were well segregated. These 
indicates that ferrimagnetic MFe2O4 (M=Ni, Co and Mg) nanoparticles that 
have well controlled size (30 ~ 40 nm) with the narrow size distribution (< 
29%) were successfully synthesized by conventional sol-gel process.  
 
 
Fig. 4-1. The sizes and the size distributions of CoFe2O4 (28.7 nm ±6.7 nm), 




4.1.2. AC Magnetically Induced Heating Characteristics of Ferrimagnetic 
MFe2O4 (M=Ni, Co and Mg) Nanoparticles 
 
   The TAC,mag of ferrimagnetic MFe2O4 (M=Ni, Co and Mg) nanoparticles 
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frequency (110 kHz). Ferrimagnetic nanoparticles that had around 30~40 nm 
size and size distribution of 23~28% were chosen since the ideal size for 
ferrimagnetic nanoparticle is less than 50 nm [76]. This is because that the 
particles in the size range of 50-150 nm are typically cleared by the Kupffer 
cells of a liver [77].  
 
 
Fig. 4-2. AC magnetically induced heating characteristics of MFe2O4 (M=Co, 
Ni, Mg) 
 
   As can be seen in Fig. 4-2, MgFe2O4 showed the highest TAC,mag (ΔT = 33 
˚C) after applying the AC magnetic field at 300 seconds. On the other hand, 
NiFe2O4 (ΔT = 28 ˚C) showed relatively lower TAC,mag, in particular, CoFe2O4 
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4.1.3. The Magnetic Properties of Ferrimagnetic MFe2O4 (M=Co, Ni and 
Mg) 
 
Fig. 4-3. The magnetic major/minor systeresis loops of MFe2O4 (M=Co, Ni, 
Mg) 
 
   In order to investigate the relationship between the magnetic properties 
and TAC,mag, magnetic major/minor hysteresis loops and initial M-H curve of 
MFe2O4  (M=Co, Ni, Mg) were measured by VSM. DC minor hysteresis 
behavior of the nanoparticles was investigated by sweeping the magnetic field, 
Happl, of ± 140 Oe at room temperature (RT). As can be seen in Fig. 4-3 (b), 
the MgFe2O4 and the NiFe2O4 nanoparticles showed relatively large DC minor 
hysteresis area indicating that TAC,mag was caused by DC minor hysteresis loss. 
This is because that the relationship between TAC,mag and DC minor hysteresis 
loss can be explained by considering physical models relevant to the 
“magnetic hysteresis loss”, especially DC minor hysteresis loss (or loss power, 
Physteresis loss) which dominantly contributes to the Ptotal (total heating power) for 
ferrimagnetic nanoparticles [78]. Physteresis loss can be expressed by the 
following equation (4-4), 
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where, μ0 is the permeability of free space (4π x 10-7 H/m) and A is the area of 
hysteresis loop. However, although the CoFe2O4 nanoparticles showed a large 
hysteresis loss at the sweeping field, Happl, of ± 15 kOe, they had almost zero 
DC minor hysteresis loss with very small magnetization value at the Happl of ± 
140 Oe. This is mainly though to be due to their high magnetic anisotropy [78].  
 
 
Fig. 4-4. Iinitial M-H curve of MFe2O4 (M=Co, Ni, Mg) 
 
   Initial M-H curve of MFe2O4 (M=Co, Ni, Mg) are shown in Fig. 4-4. As 
illustrated in Fig. 4-4, MgFe2O4 and NiFe2O4 nanoparticles showed fast 
response to the applied magnetic fields less than 1000 Oe indicating that softer 
magnetic properties gave rise to large DC minor hysteresis loss. In contrast, 
CoFe2O4 that showed hard magnetic properties resulted in no hysteresis loss. 






CHAPTER 4. RESULTS & DISCUSSION 
                         𝝌 =  𝝌′ +  𝒉𝝌"……………….….….……..(4-5) 
 
                            𝑴 =  𝝌𝑯…..…………….….…………(4-6) 
 
In-phase susceptibility (χ′) is directly related to DC minor hysteresis loss, 
which causes larger magnetization. This magnetic softness (or magnetic 
exchange coupling) can be one of important factors for higher heating power 





   In-vitro cytotoxicity of the ferrimagnetic MFe2O4 (M=Co, Ni, Mg) 
nanoparticles were investigated by employing MTT assay (methylthiazol 
tetrazolium bromide test) using normal rat liver epidermal cells to evaluate the 
feasibility to a local hyperthermia agent. Fig. 4-5 shows the cell survival rate 
of the ferrimagnetic MFe2O4 (M=Co, Ni, Mg) nanoparticles under different 
nanoparticle concentrations. As can be seen in Fig. 4-5, the MgFe2O4 and 
CoFe2O4 nanoparticles showed high cell survival rates of 90% ~ 80 % (non-
cytotoxicity) but the NiFe2O4 showed slightly lower cell survival rates of 87 % 
~ 65 % (mid-cytotoxicity) with standard deviations of 8 % ~ 10 % depending 
on the nanoparticle concentrations. The relatively high biocompatibility of the 
MgFe2O4 and CoFe2O4 nanoparticles demonstrated that they can be potentially 






CHAPTER 4. RESULTS & DISCUSSION 
 
Fig. 4-5. Cell survival rate of all the ferrimagnetic MFe2O4 (M=Co, Ni, Mg) 




4.2. Ferrimagnetic MgFe2O4 Nanoparticles Modified by Modified Sol-gel 
Method 
 
   In this section, ferrimagnetic MgFe2O4 nanoparticles which exhibited 
faster frequency response, higher biocompatibility and higher TAC,mag were 
thermally, chemically and mechanically modified by modified sol-gel 
synthesis process in order to achieve higher SLP while maintaining a small 
size and a narrow size distribution for intra-arterial hyperthermia agent 
applications. 
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   Calcining process allows the constituents to interact by inter-diffusion of 
their ions and so reduces the extent of the diffusion that must occur during 
sintering in order to obtain a homogeneous body [79]. The calcining 
temperature is also an important factor in controlling shrinkage during 
sintering. By controlling calcining temperature, the size and size distribution 
of nanoparticles can be controlled [80-83].  
   In this part, we controlled calcining temperatures (400 ˚C, 500 ˚C and 600 
˚C) during the modified sol-gel method. For the sake of investigating the 
effect of calcining temperatures on the synthesized nanoparticles, the mean 
size and the size distribution as well as magnetic major/minor hysteresis loops, 
initial M-H loop and AC heating characteristics were measured. The samples 
were calcined at 400 ˚C, 500 ˚C and, 600 ˚C, respectively for 1 hour. Then, 
after a grinding process they were sintered at 700 ˚C for 6 hours, respectively 
(Sample A, Sample B and Sample C). 
 
4.2.1-1. Physical Properties   
 
   In order to investigate the effects of calcining temperature on the crystal 
structure, the mean particle size and the size distribution of the samples A, B 
and C were measured by XRD and FE-SEM. The XRD patterns of samples A, 
B, and C, are shown in Fig. 4-6. As can be seen in Fig. 4-6, the diffraction 
peaks showed a well defined single-phase cubic spinel structure and the 
synthesized nanoparticles did not exhibit any undesirable crystalline phase. 
Also, lattice parameters of the sample A, B and C were calculated based on 
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sample C that showed 8.37 Å had less defect than the sample A and B because 
it is close to that of bulk MgFe2O4 (8.36 Å). 
 
 
Fig. 4-6.  XRD patterns of the sample A(400 °C), B(500 °C) and C (600 °C) 




The mean particle size and the size distribution determined by an FE-SEM are 
shown in Fig. 4-7. Sample A (36 ±10 nm, Sdv.: ±27 %), B (37 ±11 nm, Sdv.: 
±29 %), and C (58 ±13 nm, Sdv.: ±22 %) had a round shape and were well 
segregated. These indicated that the MgFe2O4 nanoparticles that have well 
controlled size (approaching to 50 nm) with the narrow size distribution (< 
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Fig. 4-7.  The sizes and the size distributions of the sample A (36 nm ±10 nm), 












CHAPTER 4. RESULTS & DISCUSSION 




Fig. 4-8. The AC magnetically induced heating characteristics of the sample A, 
B and C in solid state (60 mg) at the biologically tolerable range of frequency 
and magnetic field (fappl = 110 kHz, Happl = 140 Oe). 
 
   The TAC,mag of samples A, B and C (solid state, 60 mg) were measured to 
investigate the effect of calcining temperatures on TAC,mag, which is shown in 
Fig. 4-8. As can be seen in Fig. 4-8, sample C showed the highest TAC,mag (ΔT 
= 93 ˚C) after applying the AC magnetic field at 1000 seconds. Even though 
sample A (ΔT = 56 ˚C) and sample B (ΔT = 63 ˚C) showed relatively low 
TAC,mag in comparison with sample C, the TAC,mag of all samples was increased 
in comparison with previous one synthesized by conventional sol-gel method.  
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Fig. 4-9. Magnetic major hysteresis loop of the sample A, B, C. 
 
   In order to explore the effect of calcining temperatures on the magnetic 
properties, the magnetic major hysteresis loop was measured. As can be seen 
in Fig. 4-9, sample C showed slightly higher Ms (saturation magnetization, 
24.5 emu/g) than sample A (19.7 emu/g) and B (20.4 emu/g), which 
approaches that of bulk MgFe2O4 as (27 emu/g). This was because the 
calcining temperature at 600 ˚C enabled the nanoparticles to have few defects 
and enhanced crystalline structure leading to higher magnetization. Some 
defects on the surface of nanoparticles might have surface disorder spins, 
which is unable to completely align all spins of nanoparticles in the direction 
of applied magnetic field leading to relatively less saturation magnetization. In 
addition, the coherent magnetization reversal of the sample C caused by the 
relatively larger particle size and wider size distribution (58 nm ± 13 nm) 
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Fig. 4-10. (a) Magnetic minor hysteresis loops of the sample A, B, C and the 
previous sample by conventional sol gel method at the sweeping field of ±140 
Oe (b) The initial M-H loops of the sample A, B, C. 
 
 
   For the sake of investigating the physical reasons of the highest TAC,mag of 
sample C, magnetic minor hysteresis loop at the sweeping field of ±140 Oe 
and initial M-H loop of the samples were measured (Fig. 4-10 (a) and (b)). As 
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response to the magnetic field. To quantitatively compare AC heat generation 
ability, the hysteresis loss energy, Physteresis loss and Ptotal of the samples were 
calculated based on the experimentally measured results, which is shown in 
table 1. The Ptotal was determined from equation (4-7), 
 
                                𝑷𝒉𝒍𝒉𝒂𝒍 = 𝑫𝒗𝒍𝒍𝒎𝜟𝑻.....................................(4-7) 
 
where, Cvol is volumetric heat capacity, m is mass of nanoparticles and ΔT is 
AC heating temperature rise. The sample C showed the largest hysteresis loss 
energy and the largest Physteresis loss which was directly relevant to Ptotal. It 
indicates that the highest TAC,mag of the sample C was caused by the largest 
DC minor hysteresis loss power. For all samples, more than 96% of Physteresis 
loss contributed to the Ptotal, which strongly demonstrates that the DC minor 
hysteresis loss power is a critical factor for determining the TAC,mag of 
ferrimagnetic nanoparticles. 
 
Table 4-1. Calculation results of hysteresis loss energy and the real 
contributions of Phystersis loss to the Ptotal of the sample A, B, C and previous one 
synthesized by conventional sol-gel method. 
 
Furthermore, the DC minor hysteresis loss is directly related to DC magnetic 





CHAPTER 4. RESULTS & DISCUSSION 
enables a faster response of magnetic spins to the applied magnetic field 
caused by a larger magnetic exchange energy (or lower magnetic anisotropy), 
which result in a higher initial χm and χ´m. Based on the equation (4-4), (4-5) 
and (4-6), it causes a larger DC magnetization value as well as a larger 
Physteresis loss. As can be seen in Fig. 4-10 (b), sample C showed the softest 
magnetic properties in response to the magnetic field, which closely 
contributed to higher magnetization leading to the largest DC minor hysteresis 
loss. On the other hand, the previous sample showed the smallest hysteresis 
loss, which resulted in the lowest AC heating power.  
   
 
Fig. 4-11. (a) The comparison of the Ms and Hc depending on the sample 
A, B and C (b) Hc depending on the mean particle size of the sample A, 
B and C. 
 
   In order to verify the reason of the higher magnetic softness of the sample 
C, the Ms and Hc (coecivity) of the synthesized nanoparticles were compared 
based on the calcining temperature and the size, which is shown in Fig. 4.11 (a) 
and (b), respectively. As can be seen in Fig. 4.11 (a), Ms were increased but Hc 
were decreased at calcining temperature 600 ˚C. It looked like to approach 
further to multi-domain region resulting in a smaller coecivity and a higher 
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softer magnetic property due to low anisotropy energy caused by the 
minimized magnetic static energy of multi-domains. While, the sample A and 
B were in the single domain region with relatively lower Ms and higher Hc, 
which resulted in relatively hard magnetic property than that of the sample C.  
 
 
Fig. 4-12. The AC magnetically induced heating characteristics of the sample 
A, B and C in liquid state (5mg/ml in toluene) at the biologically tolerable 
range of frequency and magnetic field (fappl = 110 kHz, Happl = 140 Oe). 
 
   To evaluate AC magnetically induced heating characteristics in liquid state 
for the feasibility to a in vivo hyperthermia agent, the samples (A, B and C) 
were well dispersed in toluene and the TAC,mag were measured in liquid state (5 
mg/ml). As shown in Fig. 4-12, the sample C showed the highest TAC,mag (ΔT 
= 4.32 ˚C) in liquid state. The sample B (ΔT = 3.46 ˚C) and A (ΔT = 3.38 ˚C) 
generated less TAC,mag, which was illustrated the same trends as the result of 
the solid state nanoparticles. Since the nanoparticles were dispersed in toluene, 
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which demonstrated that AC heat generation of the sample C from magnetic 
dipole interaction was quite small.  
 
 
Fig. 4-13. Spicific loss power (SLP) of the samples in the range of frequency 
and magnetic field (fappl = 110 kHz, Happl = 140 Oe). 
 
   Fig. 4-13 shows SLP of the samples in the range of the magnetic field 
(Happl = 140 Oe) and frequency (fappl = 110 kHz). The sample C showed the 
highest SLP (600 W/g) among the samples.  
 
 
4.2.2. Ferrimagnetic MgFe2O4 Nanoparticles Modified by Sintering 
Process 
 
   In the previous part, we demonstrated that calcining temperature at 600 ˚C 
enhanced the SLP of ferrimagnetic MgFe2O4 nanoparticles. However, the 
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size distribution (58 nm ± 13 nm). In order to inject the nanoparticles through 
intra-arterial way without clotting problems and capturing by Kupffer cell of 
liver, the mean size and the size distribution of nanoparticles should be smaller 
and narrower as possible. Therefore, in order to optimize the synthesis 
conditions for a smaller particle size, a narrower distribution and a higher SLP, 
the ferrimagnetic MgFe2O4 was modified by sintering process with different 
temperatures (700 ˚C, 750 ˚C, 800 ˚C, 850 ˚C and 900 ˚C) during the modified 
sol-gel method. All samples were calcined at 600 ˚C, respectively for 1 hour. 
Then, after a grinding process they were sintered at 700 ˚C, 750 ˚C, 800 ˚C, 
850 ˚C and 900 ˚C for 6 hours, respectively (Sample D, Sample E, Sample F, 
Sample G, and Sample H). Then, crystal structure, particle size, minor 
hysteresis loop and TAC,mag were measured depending on the sintering 
temperatures. 
 
4.2.2-1. Physical and Magnetic Properties & AC Magnetically Induced 
Heating Temperature (TAC,mag) 
 
   In order to investigate the effects of sintering temperature on the crystal 
structure, mean particle size and size distribution of the all samples, XRD and 
FE-SEM were measured. The XRD patterns are shown in Fig. 4-14 (a), which 
did not show any undesirable crystalline phase and also showed a single-phase 
cubic spinel structure. The mean particle size and the size distribution 
determined by an FE-SEM were plotted versus the sintering temperature, 
which is shown in Fig. 4-14 (b). The samples were D (58 ± 11 nm), E (60 
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the size of the nanoparticles was continuously increased depending on the 
sintering temperatures and was significantly increased after 850 ˚C (> 100 nm). 
Overall size was too big to be used for an intra arterial hyperthermia agent.   
 
 
Fig. 4-14. (a) The XRD patterns of the samples (b) The mean size depending 
on sintering temperature. 
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   In order to explore the effect of sintering temperatures on the magnetic 
properties and TAC,mag, the magnetic DC minor hysteresis loop and TAC,mag 
were measured and compared, which is shown in Fig. 4-15. As can be seen in 
Fig. 4-15 (a), DC minor hysteresis loss was increased with increase in 
sintering temperature, which well corresponded with the TAC,mag in Fig. 4-15 
(b). The increased particle size was likely to cause higher magnetization with 
larger DC minor hysteresis loss allowing higher the TAC,mag. Even though the 
highest TAC,mag was shown at sample H, sample G showed the highest rate of 
temperature rise (Fig. 4-15 (b)) indicating that the sintering temperature of 850 
˚C was likely to be considered as the synthesis condition for highly efficient 
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Fig. 4-15 (a) Magnetic minor hysteresis loop (b) The AC magnetically induced 
heating temperature and the rate of temperature rise depending on the 
sintering temperature in solid state (60 mg) at the biologically tolerable range 




4.2.3. Ferrimagnetic of MgFe2O4 Nanoparticles Modified by Ball Milling 
Process 
 
   The process in which small particles are produced by reducing the size of 
larger ones by mechanical forces is usually referred to as communication. It 
involves operations such as crushing, grinding and milling. Ball mills are 
categorized into various types depending on the method used to impart motion 
to the balls (e.g., tumbling, vibration, and agitation) [84]. Tumbling ball mill, 
usually referred to simply as ball mills, consist of a slowly rotating horizontal 
cylinder that is partly filled with grinding balls and the particles to be ground.  
   In the previous parts, we demonstrated that sintering temperature at 850 ˚C 





CHAPTER 4. RESULTS & DISCUSSION 
was too high to use it as hyperthermia agent (~ 100 nm). Therefore, in order to 
reduce the size while maintaining the rate of temperature rise, the 
ferrimagnetic MgFe2O4 modified by ball milling process with the different 
size of balls (No ball milling, 5 mm, 3 mm); sample I, sample J and sample K, 
respectively during the modified sol-gel method, was investigated.  
 
4.2.3-1. Physical and Magnetic Properties 
 
   In order to investigate the effects of ball milling process on the mean 
particle size and the size distribution of the samples, the sample I, J and K 
were measured by FE-SEM, which is shown in Fig. 4-16. The sample I (101 
±33 nm, Sdv.: 32 %), J (67.4 ±19.6 nm, Sdv.: 29%), and K (40.7  ±8.7 nm, 
Sdv.: 21.3 %) were well segregated. The particle mean size and size 
distribution of the samples decreased with decrease in the size of the ball. This 
indicated that ferrimagnetic MgFe2O4 nanoparticles modified by ball milling 
process were successfully synthesized and corresponded well with the 
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Fig. 4-16. The mean particle sizes and its size distributions of the sample I 
(101 ±33 nm, Sdv.: 32 %), J (67.4 ±19.6 nm, Sdv.: 29%), and K (40.7  ±8.7 
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Fig. 4-17.  Magnetic major hysteresis loop of the sample I, J and K. 
 
   In order to explore the effect of ball milling process on the magnetic 
properties, the magnetic major hysteresis loop of the samples was measured by 
VSM. As can be seen in Fig. 4-17, the sample I showed high Ms with coherent 
magnetization reversal owing to low anisotropy energy of multi domains 
caused by a large particle size as well as due to higher particle dipole 
interaction (E int) and higher exchange coupling energy (Jex) caused by the 
widest size distribution (32%) [78]. The sample J showed slightly less Ms than 
that of the sample I, but it still showed coherent magnetization reversal, which 
means it was in multi domain regions but smaller size and narrower size 
distribution than that of the sample A. However, for sample K, the hysteresis 
loop seemed like superparamagnetic characteristics due to relatively high 
anisotropy energy of single domain caused by small particle size as well as 
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small Jex , which means there were few magnetic dipole interactions among 
the nanoparticles.  
 
4.2.4. AC Magnetically Induced Heating Characteristics in Solid State 
and Liquid States 
 
4.2.4-1. Oleic Acid Coating Process 
 
 
Fig. 4-18. Schematic of oleic acid coating 
 
   In order to measure SLP (Specific Loss Power) and mix with lipiodol, the 
nanoparticles were coated with oleic acid. As can be seen in Fig. 4-18, oleic 
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4.2.4-2. AC Magnetically Induced Heating Characteristics  
 
   For the sake of investigating the AC heating abilities of the synthesized 
nanoparticles in solid states and ferrofluids, the TAC,mag of the sample with and 
without OA coating were measured, respectively (Fig. 4-19 (a) and (b)). For 
the TAC,mag in solid states as illustrated in Fig. 4-19 (a), the sample I showed 
the highest heating temperature (ΔT = 126 ˚C). The sample J was 98 ˚C (=ΔT) 
and the sample K was 65 ˚C (=ΔT). However, for the TAC,mag of the OA coated 
nanoparticles, measured in ethanol (Concentration: 5 mg/ml) as can be seen in 
Fig. 4-19 (b), the results were completely reserved. The sample C, displayed 
the lowest TAC,mag (ΔT = 65 ˚C) in solid state, showed the highest TAC,mag (ΔT 
= 5.1 ˚C) in ferrofluids but the sample I showed the lowest TAC,mag (ΔT=4.26 
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Fig. 4-19.  The AC magnetically induced heating characteristics of the 
sample I, J and K in (a) solid state (60 mg) and (b) liquid state (5 mg/ml in 
ethanol) at the biologically tolerable range of frequency and magnetic field 




4.2.4-3. Magnetic Properties and Coating Conditions 
 
 
Fig. 4-20. (a) Magnetic DC minor hysteresis loops of the samples I, J and K in 
solid states (b) Magnetic DC minor hysteresis loops of the OA coated sample I, 
J and K in ferrofluids. 
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minor hysteresis loops in solid states and ferrofluids (the OA coated samples) 
were measured and compared. As illustrated in Fig. 4-20 (a), the sample I 
showed the largest DC minor hysteresis area due to coherent rotation of 
dipoles or domains caused by low anisotropy of multi domains and magnetic 
dipole interactions caused by wide size distribution in the response to the 
magnetic field. This can be well explained by the heating mechanism of 
ferromagnetic nanoparticles (FMNPs) owing to hysteresis loss power (Physteresis 
loss) that is mainly contributed to total AC heating power (Ptotal) in solid states 
[85]. Then, the hysteresis area of the sample J is larger than that of the sample 
K due to relatively higher MS and faster coherent rotation of multi domains. 
The sample K seemed to like hard magnetic properties in the range of ±140 Oe 
leading to the lowest DC minor hysteresis loss. This was because that the 
sample K was closer to single domain region with relatively higher anisotropy 
and lower magnetization due to the smaller mean size and few magnetic dipole 
interaction, precluding from easily rotating magnetic dipoles in response to the 
small range of the magnetic field. However, in the ferrofluids, the magnetic 
DC minor hysteresis loss of the sample K was significantly increased in 
comparison with that in solid states while that of the sample I was 
significantly decreased in comparison with that in solid states. Due to 
ferrofluid status, meaning that the nanoparticles were coated with OA and well 
dispersed in ethanol, magnetic dipolar interactions among the coated 
nanoparticles were completely changed in comparison with that in solid states. 
Therefore, the AC heating mechanism in ferrofluids should be considered 
based on magnetic dipolar interaction and coating status. First of all, the 
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magnetic interaction than that in solid states. Instead, the contribution of 
Relaxation loss power (Prelaxation loss) to Ptotal might be increased owing to the 
separated nanoparticles in liquid states. It means that smaller particles size can 
reduce Neel relaxation time as well as smaller hydrodynamic diameter can 
reduce Brownian relaxation time leading to large PNeel relaxation loss based on the 
bellow equations,  
 
               𝑷𝒉𝒉𝒍𝒂𝒓𝒂𝒉𝒉𝒍𝒎 𝒍𝒍𝒉𝒉 = 𝝅𝝁𝟎𝝌𝟎𝑯𝟎𝟐𝒇 𝟐𝝅𝒇𝝉𝟏+(𝟐𝝅𝒇𝝉)𝟐  ………….(4-8) 
 
,where µ0 is the permeability of free space, χ0 is the equilibrium susceptibility, 
H0 and f are the amplitude and the frequency of alternating magnetic field and 
τ is the effective relaxation times given by, 
 









,where τN and τB are the Neel relaxation and Brownian relaxation time, 
respectively. τN and τB are written as  
 
                      𝝉𝑵 = 𝝉𝟎𝒉𝒓𝒂�𝑲𝑲𝒌𝑩𝑻� ………….…….……(4-10) 
                     𝝉𝑩 = 𝟑𝑲𝒉𝒉𝒅𝟑𝜿𝑩𝑻 = 𝝅𝑫𝒉𝒉𝒅𝟑 𝟑𝟐𝜿𝑩𝑻  ……….……..……..(4-11) 
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is magnetic anisotropy energy density, V is its volume, τ0 is the Boltzmann 
constant and T is the absolute temperature. η is the dynamic viscosity of the 
suspending medium, Vhyd and Dhyd denote the hydrodynamic particle volume 
and diameter, respectively. 
 
 
Fig. 4-21. Hydrodynamic diameter measured by DLS. 
 
   In order to investigate the coating conditions of the samples, 
hydrodynamic diameter and PDI (Polydispersity index) were measured by 
DLS (Dynamic light scattering), which is shown in Fig. 4-21. The size 
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samples are summarized in Table 4-2. As can be seen in table 4-2, the sample 
K showed the smallest mean size and narrowest size distribution in solid state 
and exhibited the smallest hydrodynamic diameter and PDI in liquid state. 
This indicated that the smaller size nanoparticle and narrower size distribution 
thought to be well and separately coated with oleic acid, allowing smaller 
hydrodynamic diameter and PDI. It enables large Prelaxation loss as well as 
Physteresis loss that resulted from larger DC minor hysteresis loss caused by the 
well coated and dispersed nanoparticles without magnetic dipole interaction in 
the response to magnetic field in ferrofluids.  
 
Table 4-2. Mean size measured by FE-SEM and hydrodynamic diameter and 
PDI measured by DLS 
 
   In contrast, sample I which had the largest size and widest size distribution 
thought to be not well coated due to the agglomeration of the nanoparticle, 
which resulted in the largest hydrodynamic diameter and PDI. It might show 
less Prelaxation loss and Physteresis loss that resulted from high magnetic dipolar 
coupling among the agglomerated nanoparticles, precluding magnetic dipole 
from rotating quickly to the applied magnetic field [86]. Therefore, for the 
heating mechanism in ferrofluids, the smaller particle size and narrower size 
distribution as well as the coating conditions of nanoparticles could be very 
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coated nanoparticles and mono-dispersion status are desirable for efficient AC 
heating generation.    
 
4.2.4-4. Specific Loss Power (SLP)  
 
 
Fig. 4-22. SLP of the sample I, J, K 
 
 
   For the evaluation of AC heating performance of the samples, SLP of the 
samples were calculated. As can be seen in Fig. 4-22, even though the sample 
I showed the highest TAC,mag in solid states, it exhibited the lowest TAC,mag in 
liquid states. This is because that Brownian relaxation time was long due to 
the large size of hydrodynamic diameter as well as large PDI was high owing 
to large particle size and wide distribution. On the other hand, the sample K 
showed highest SLP in liquid state because it had the smallest particle size 
(~40 nm) and the narrowest size distribution (~21%) due to the mechanical 
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diameter and PDI due to the well coated mono-dispersion condition, leading to 
the enhancement of Brownian relaxation loss as well as hysteresis loss. SLP of 
the sample K showed the highest SLP (525 W/g), which is higher than that of 
Fe3O4 nanoparticles (120 W/g) currently used (Size = 25 nm, Happl = 300 Oe, 
fappl= 120 kHz) [86]. 
 
4.2.5. Emulsion Formation with Lipiodol and AC Heating Characteristics 
in Emulsion States   
 
   Lipiodol (Andre Guerbet, Aulnay-sous-Bios, France) also known as 
iodized oil is to function as a contrast agent, as a vehicle for chemotherapeutic 
agents, and as an embolic agent for Transcatheter arterial chemoembolization 
(TACE) [87]. In the early 1980s, it was found for lipiodol to remain selectively 
in the neovasculature and extravascular spaces of hepatocellular carcinoma 
(HCC) when injected into the hepatic artery [88, 89]. Thereafter, TACE with 
lipiodol emulsion and various anticancer drugs has been used as a standard 
treatment for unresectable or post peratibely recurrent HCC and as alternative 
to surgery, even for resectable tumors [90, 91].  
   In this part, in order to evaluate the feasibility of ferrimagnetic MgFe2O4 
for the clinical use of liver cancer treatment in intra-arterial hyperthermia 
modality, the oleic acid coated nanoparticles were mixed with lipiodol for the 
emulsion formation. Also, the TAC,mag of the mixed emulsion was measured.  
 
 









Fig. 4-23. Emusion formation with lipiodol by pumping method 
 
   For the emulsion state, pumping method using three way cock and 
syringes was required. As can be seen in Fig. 4-23, two syringes were 
connected by three way cock and the contents were mixed by pumping 
syringes several times enough to be completely mixed until water in oil 
formation of the emulsion formed. However, it diminished soon due to the 
differences of specific gravities between the coated nanoparticles and lipiodol. 
For the optimal ratio between the coated nanoparticles and lipiodol for 
emulsion state, various ratio of lipiodol and the coated nanoparticles (2:1, 6:1 
and 30:1) were mixed and observed for 30 minutes and 1 hour 30 minutes, 
which is shown in Fig. 4-24. It indicated that the ratio of 6:1 is proper ratio 
between the coated nanoparticle and lipiodol sustaining the emulsion 





CHAPTER 4. RESULTS & DISCUSSION 




Fig. 4-24. Emusion formation with lipiodol depending on mixing rate 
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Fig. 4-25. The AC magnetically induced heating characteristics of the sample 
A, B and C in (a) solid state (60 mg) and (b) liquid state (5 mg/ml in ethanol) 
at the biologically tolerable range of frequency and magnetic field (fappl = 110 
kHz, Happl = 140 Oe). 
 
   In order to estimate the heating performance in emulsion state, the TAC,mag 
of the sample K mixed with lipiodol were measured in emulsion state where 
the coated nanoparticles were well dispersed (5 mg/ml). As shown in Fig. 4-25, 
AC magnetically heating characteristics of the emulsion state showed slightly 
lower heating rate verse time. This was because the viscosity of lipiodol is 
quite higher (oil states) than ethanol causing increase in Brownian relaxation 
time, which reduce Brownian loss. However, TAC,mag of both at 2000 seconds 
were not too different indicating that this emulsion can be suitable for the 











   In the first part, ferrimagnetic MFe2O4 (M=Co, Ni, Mg) nanoparticles were 
synthesized by the conventional sol-gel method to evaluate the feasibility for 
intra-arterial hyperthermia agent applications. The mean particles size, size 
distribution and magnetic properties of all samples were investigated. The 
TAC,mag of the samples in the size range of 30~40 nm, was measured in solid 
state. In addition, biocompatibility test using normal rat liver epidermal cells 
was investigated for evaluating the feasibility of hyperthermia agent 
applications. The ferrimagnetic MgFe2O4 nanoparticles showed the highest 
TAC,mag due to the softer magnetic properties and exhibited the highest 
biocompatibility properties among the synthesized ferrimagnetic nanoparticles. 
It demonstrated that ferrimagnetic MgFe2O4 nanoparticles can be suitable for 
intra-arterial hyperthermia applications.  
   In the second part, ferrimagnetic MgFe2O4 nanoparticles were synthesized 
by the modified sol-gel method in order to enhance the crystal structure, mean 
particle size, size distribution, and AC heating generation properties for the 
clinical use of liver cancer treatment in intra-arterial hyperthermia modality. 
Ferrimagnetic MgFe2O4 nanoparticles were synthesized by controlling 
calcining temperatures (400 °C, 500 °C and 600 °C) with the fixed sintering 
temperature (700 °C). Even though the sample C (calcining temperature at 
600 °C) showed the highest TAC,mag and SLP in solid state and liquid state 
caused by the improvement of magnetic softness and saturation magnetization 
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energy of multi-domains, it showed slightly the larger mean particles size (58 
nm) than the ideal size (< 50 nm) as well as wider size distribution (±13 nm). 
Accordingly, ferrimagnetic MgFe2O4 nanoparticles were synthesized by 
controlling sintering temperatures (700-900 °C) with the fixed calcining 
temperature (600 °C) to improve the properties. Even though the sample G 
(sintering temperature at 850 ˚C) was showed the highest rate of temperature 
rise, the size of the nanoparticle was too high to be used it as a hyperthermia 
agent (~ 100 nm). Therefore, ball milling process with different ball sizes (5 
mm, 3 mm) was added in the processes between the fixed calcining 
temperature (600 °C) and sintering temperature (850 °C) in order to 
mechanically modify the properties of the nanoparticles. The particle size and 
size distribution, magnetic properties as well as TAC,mag in solid state and 
liquid state of the modified nanoparticles were measured and compared. Even 
though the sample K (ball milling process using 3 mm grinding ball) that had 
proper particle size (~40 nm) and narrower size distribution (~21%), it showed 
the lowest TAC,mag in solid state, however, it showed the highest TAC,mag and 
SLP (525 W/g) in liquid state after oleic acid coating. This was because the 
smallest particle size and the narrowest size distribution enabled the  
enhancement of Neel relaxation loss and coating conditions leading to the 
smallest hydrodynamic diameter and PDI, which enhanced Brownian 
relaxation loss and hysteresis loss in ferrofluids. In addition, the TAC,mag in the 
emulsion solution where the oleic acid coated nanoparticles were mixed with 
lipiodol was measured to evaluate the feasibility for clinical applications. This 
sample also showed good TAC,mag in the emulsion solution. All the results, in 
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synthesized by the modified sol-gel method can be suitable for the clinical use 
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